Helen Nelson possesses extensive experience in business development and management within the clinical research industry. Currently serving as Senior Director of Business Development & Client Management at CTI Clinical Trial and Consulting Services since May 2023, Helen has previously held senior roles at PSI CRO AG and Simbec Orion Group, where responsibilities included directing business development and proposal development. Prior to these positions, Helen's career featured significant roles at Surrey Clinical Research Centre, Cardiff Research Consortium, Novartis, and Andaris. Helen holds a PhD in Pharmaceutics from Cardiff University, an MBA from Lancaster University, and a Bachelor of Pharmacy with Honors from King’s College London.